Antibody-mediated Rejection

Also known as: Transplant rejection / Transplant rejections / Graft Rejection

DrugDrug NameDrug Description
DB00098Antithymocyte immunoglobulin (rabbit)A purified form of rabbit anti-thymocyte antibodies used for immunosuppression in patients receiving kidney transplants.
DrugDrug NamePhaseStatusCount
DB12849Clazakizumab1 / 2Active Not Recruiting1
DB12849Clazakizumab1 / 2Recruiting1
DB09331Daratumumab1 / 2Not Yet Recruiting1
DB00098Antithymocyte immunoglobulin (rabbit)2Recruiting1
DB06681Belatacept2Recruiting1
DB06681Belatacept2Withdrawn1
DB00188Bortezomib2Completed1
DB08889Carfilzomib2Withdrawn1
DB12849Clazakizumab2Active Not Recruiting1
DB01257Eculizumab2Terminated1
DB00028Human immunoglobulin G2Terminated1
DB00959Methylprednisolone2Recruiting1
DB00688Mycophenolate mofetil2Recruiting1
DB01024Mycophenolic acid2Recruiting1
DB00635Prednisone2Recruiting1
DB00864Tacrolimus2Recruiting1
DB12849Clazakizumab3Recruiting1
DB05341Human C1-esterase inhibitor3Recruiting1
DB00028Human immunoglobulin G3Not Yet Recruiting1
DB00959Methylprednisolone3Not Yet Recruiting1
DB00073Rituximab3Not Yet Recruiting1
DB01257Eculizumab4Active Not Recruiting1
DB00188BortezomibNot AvailableRecruiting1